Wrist-worn pulse oximetry is a user-friendly non-invasive medical device used to deliver highly accurate reading associated with the studies such as oxygen saturation level, pulse rate, and heart rate. Conditions such as respiratory diseases, sleep problems, and cardiac diseases can be detected early with the help of this device. Due to the growing prevalence of chronic obstructive pulmonary disease (COPD), there is a surge in the utilization of wrist-worn pulse oximetry devices, according to the World Health Organization (WHO), around 3.17 million individual died of COPD in 2015.
Safety lancets are the single-use blood-sampling device. Needlestick injuries and associated infections are well contained with the use of safety lancets. Lancets are widely used in hospitals, clinics, and laboratories due to certain suitable characteristics, such as easy handling, painless vein puncture, and safe usage. These are available in wide range of designs providing comfortable, secure, and simple puncture.
Demand for automotive diagnostic scan tools is expected to witness strong growth due to increasing electrification of vehicles worldwide. Automotive diagnostic scan tools are combination of electronic devices and software that are used as interface with diagnostic systems in vehicles. These tools are used for identifying faults or malfunctions in electric systems of vehicles by simply plugging cable into a diagnostic connector and running full scan.
Automotive Garage Equipment Market is expand at a CAGR of 5.5% between 2025 and 2033. Booming automotive sector has given substantial rise to a burgeoning automotive garage equipment market. With consistent rise in automotive sales, the related service & maintenance sector has demonstrated immense growth over the period of time. Apart from authorized service centers, multi-brand service centers have come into existence, thereby driving additional demand for related garage equipment.
The lyme disease diagnostics market plays a pivotal role in the early detection and treatment of Lyme disease, a vector-borne illness caused by the bacterium Borrelia burgdorferi. The lyme disease diagnostics market is expected to grow at a CAGR of 3.6% during the forecast period of 2025 to 2033, driven by the increasing incidence of Lyme disease, advancements in diagnostic technologies, and growing awareness. Despite the limitations in early-stage diagnosis, PCR tests are expected to lead in terms of CAGR.
Laryngoscopes Market Is Projected to Expand At A CAGR Of 5.1% Between 2025 And 2033. Laryngoscopy refers to the medical examination of the larynx for the purpose of visualization of vocal cords, upper tracheal rings etc. Laryngoscopes are used for diagnosis of voice disorders, ENT related pain, abnormalities and airway obstruction.
Clot Management Devices Market Is Projected to Expand At A CAGR Of 4.2% Between 2025 And 2033. The global clot management devices market is expected to retain steady growth due to rising prevalence of peripheral artery diseases, venus thromboelbolism, coronary diseases and so on.
Global disposable medical sensors market accounted for US$ 4,461.8 Mn in 2017 and estimated to attain US$ 8,118.7 by 2026 with a CAGR of 6.81% during the period from 2018 to 2026. Biosensors contribute a larger market share while image sensor foreseen to grow with higher CAGR.
Gonorrhea is caused due to the infection of bacterium Neisseria gonorrhea which usually affects the moist and warm areas of the body such as vagina, anus, urethra, throat and eyes. It is classified as the second most occurring sexually transmitted disease (STD) as it has the risk to spread through unprotected sex or having multiple sex partners. Due to high morbidity rate and eminent threat of gonorrhea being resistant to cephalosporin, makes it necessary to understand the disease epidemiology of gonorrhea.
Yersinia is a gram-positive bacteria causing terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children, and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, North Europe, and Scandinavian counties, therefore making these regions the largest markets for Yersinia diagnostics.
The diagnostics market includes instruments, reagents, test kits, software and related services used to detect diseases, assess patient health and support treatment decisions. Major areas include clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, microbiology, genetic testing, companion diagnostics and point-of-care testing. Hospitals, diagnostic laboratories, research institutions, physician offices and home-care users represent the market’s major customers.
The global clinical diagnostics market is projected to increase from USD 87.99 billion in 2025 to USD 150.30 billion by 2035, registering a CAGR of 5.50% from 2026 to 2035. This forecast represents clinical diagnostics; individual segments such as molecular, digital and point-of-care diagnostics may record different growth rates.
The increasing prevalence of cancer, diabetes, cardiovascular disorders and infectious diseases is a major market growth driver. Aging populations and rising awareness of preventive healthcare are increasing the demand for routine testing and early disease detection. Healthcare providers are also using diagnostic tests to monitor treatment response, determine disease risk and select suitable therapies.
Molecular diagnostics is an important growth area because it can identify genetic material, pathogens and disease-related biomarkers with high accuracy. Polymerase chain reaction, next-generation sequencing and other molecular testing technologies are increasingly used in oncology, infectious disease testing and inherited disorder screening. Companion diagnostics are also gaining importance because they help identify patients who are likely to benefit from specific targeted medicines.
Point-of-care and home-based testing represent another major trend. Portable diagnostic systems provide results close to the patient, reducing the time between sample collection and treatment decisions. Demand is growing for rapid tests, connected glucose monitors and other decentralized testing solutions. However, laboratory-based systems remain important for complex tests, high sample volumes and confirmatory analysis.
Artificial intelligence, laboratory automation and digital connectivity are changing diagnostic workflows. Automated sample handling can improve laboratory productivity and reduce manual errors. AI-supported platforms help professionals analyze test results and identify patterns, while connected diagnostic systems enable data transfer between laboratories, hospitals and electronic health records.
Market restraints include high equipment costs, strict approval requirements, reimbursement limitations and shortages of trained laboratory professionals. Differences in test quality and healthcare access may also limit adoption in developing markets. Diagnostic companies must address data security, result accuracy and system compatibility when introducing digital platforms.
North America leads the market due to developed laboratory infrastructure, high testing volumes and early adoption of advanced technologies. Europe maintains strong demand supported by established healthcare systems. Asia-Pacific is expected to offer significant growth opportunities through 2035 due to increasing healthcare expenditure, expanding diagnostic networks and rising disease screening in China, India and Southeast Asia.
Acute Market Reports provides diagnostics market research covering market size, product and technology analysis, disease applications, end users, competitive developments, regional opportunities and forecasts through 2035. These reports support diagnostic companies, laboratories, healthcare providers and investors in making informed business decisions.